Please login to the form below

Not currently logged in


This page shows the latest rheumatology news and features for those working in and with pharma, biotech and healthcare.

US ‘unicorn’ Samumed on track with lead arthritis drug

US ‘unicorn’ Samumed on track with lead arthritis drug

The San Diego company presented data at this week’s American College of Rheumatology (ACR) meeting showing that a single injection of SM04690 into the joints of people with OA of

Latest news

More from news
Approximately 1 fully matching, plus 68 partially matching documents found.

Latest Intelligence

  • Case study: Immunology education Case study: Immunology education

    There are immunological links between immune-mediated inflammatory diseases (IMIDs) in dermatology, gastroenterology and rheumatology, with patients often presenting with multiple conditions. ... Setting up a virtual biologics clinic (Manchester Royal

  • Pharma deals during April 2014 Pharma deals during April 2014

    proteinuria associated with nephrotic syndrome, certain rheumatology-related conditions, and infantile spasms. Whilst this is a 60-year old drug acquired by Questcor in 2001 for $100, 000, generic competition is

  • Pharma deals during February 2014 Pharma deals during February 2014

    in litigation over two synthetic versions of Acthar (ACTH), a corticotropin with 19 indications, many in rare diseases including infantile spasms, MS, nephrology, and rheumatology.

  • Interview: Pierre Chancel, Sanofi Diabetes Interview: Pierre Chancel, Sanofi Diabetes

    Marketing Director Theraplix,  Rhône-Poulenc. Business Unit Manager for CNS, Rheumatology and HRT, Rhône-Poulenc.

  • Interview: Deepak Khanna, ABPI Interview: Deepak Khanna, ABPI

    In 1996, Deepak joined the Worldwide Human Health Marketing Division working with rheumatology products; he later assumed responsibility for the marketing planning activities to support early stage central nervous system products.

More from intelligence
Approximately 0 fully matching, plus 9 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 8 partially matching documents found.

Latest from PMHub

  • Lucid Group welcomes new magical talent and boosts their medical writing teams with hires in the US and UK

    Hazel Urwin joins Lucid Partners as a Scientific Director. Hazel has eight years’ experience in medical communications with particular expertise in the fields of neurology, immunology and rheumatology.

  • Bringing the NHS into the 21st century

    We have consultants specialising in cardiology, endocrine, ENT, gynaecology, haematology, neurology, respiratory, orthopaedics, rheumatology, and urology.

  • Healthcircle

    Rx &Medical Devices. Oncology. Haematology. Rheumatology. Anti-infectives. Anti-virals. Cardiovascular. Respiratory. Endocrinology.


    Our diverse experience in human and animal health includes:. gastroenterology . rheumatology .

  • The Biosimilar Challenge

    In fact, recent self-funded work, showed that 89% of UK payers now positively endorse the use of biosimilars across a range of therapy areas – especially in rheumatology. ... The pressure is now on to undertake the same in rheumatology, dermatology and

More from PMHub
Approximately 2 fully matching, plus 18 partially matching documents found.

Featured jobs

Subscribe to our email news alerts


Add my company

We're a healthcare communications agency that does things differently. We put patients at the heart of everything we do, while...

Latest intelligence

Is China ready for a pharmaceutical gold rush?
Some describe doing business in China as akin to the 1990s internet boom – so how stable is its future?...
AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...